Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Temporal Tracking of Microg...
    Mathys, Hansruedi; Adaikkan, Chinnakkaruppan; Gao, Fan; Young, Jennie Z.; Manet, Elodie; Hemberg, Martin; De Jager, Philip L.; Ransohoff, Richard M.; Regev, Aviv; Tsai, Li-Huei

    Cell reports (Cambridge), 10/2017, Letnik: 21, Številka: 2
    Journal Article

    Microglia, the tissue-resident macrophages in the brain, are damage sensors that react to nearly any perturbation, including neurodegenerative diseases such as Alzheimer’s disease (AD). Here, using single-cell RNA sequencing, we determined the transcriptome of more than 1,600 individual microglia cells isolated from the hippocampus of a mouse model of severe neurodegeneration with AD-like phenotypes and of control mice at multiple time points during progression of neurodegeneration. In this neurodegeneration model, we discovered two molecularly distinct reactive microglia phenotypes that are typified by modules of co-regulated type I and type II interferon response genes, respectively. Furthermore, our work identified previously unobserved heterogeneity in the response of microglia to neurodegeneration, discovered disease stage-specific microglia cell states, revealed the trajectory of cellular reprogramming of microglia in response to neurodegeneration, and uncovered the underlying transcriptional programs. Display omitted •Transcriptomes of 1,685 individual microglia cells from healthy and diseased brains•Identification of disease stage-specific microglia cell states•Trajectory of cellular reprogramming of microglia in response to neurodegeneration•Two distinct reactive microglia phenotypes in the neurodegenerating brain Mathys et al. use single-cell RNA sequencing to determine the phenotypic heterogeneity of microglia during the progression of neurodegeneration. They identify multiple disease stage-specific cell states, including two molecularly distinct reactive microglia phenotypes that are typified by modules of co-regulated type I and type II interferon response genes, respectively.